These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3440931)

  • 1. Relative bioavailability of rimantadine HCl tablet and syrup formulations in healthy subjects.
    Wills RJ; Choma N; Buonpane G; Lin A; Keigher N
    J Pharm Sci; 1987 Dec; 76(12):886-8. PubMed ID: 3440931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence of two rimantadine tablet formulations in healthy male volunteers after single dose administration.
    Chládek J; Sispera L; Martinková J; Zaludek B; Sova P; Mièuda S; Grim J; Cermanová J; Zaludek B; Sova P; Franc A
    Int J Clin Pharmacol Ther; 2001 Apr; 39(4):179-84. PubMed ID: 11332875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability, pharmacokinetics, and bioequivalence of the tablet and syrup formulations of lacosamide in plasma, saliva, and urine: saliva as a surrogate of pharmacokinetics in the central compartment.
    Cawello W; Bökens H; Nickel B; Andreas JO; Halabi A
    Epilepsia; 2013 Jan; 54(1):81-8. PubMed ID: 23148731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rimantadine pharmacokinetics in healthy subjects and patients with end-stage renal failure.
    Capparelli EV; Stevens RC; Chow MS; Izard M; Wills RJ
    Clin Pharmacol Ther; 1988 May; 43(5):536-41. PubMed ID: 3365917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
    Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C
    Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of a meal on the bioavailability of rimantadine.HCl.
    Wills RJ; Rodriguez LC; Choma N; Oakes M
    J Clin Pharmacol; 1987 Oct; 27(10):821-3. PubMed ID: 3429689
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of rimantadine hydrochloride in patients with chronic liver disease.
    Wills RJ; Belshe R; Tomlinsin D; De Grazia F; Lin A; Wells S; Milazzo J; Berry C
    Clin Pharmacol Ther; 1987 Oct; 42(4):449-54. PubMed ID: 3665342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative bioavailability of DL-oxyfedrine HCl after single-dose oral administration of tablets as compared to equimolar solutions.
    Wetzelsberger N; Birkel M; Fuder H; Lücker PW; Stiegler S; Scheithauer S; Thümmler D
    Methods Find Exp Clin Pharmacol; 1995 Apr; 17(3):185-91. PubMed ID: 8531509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cimetidine on the disposition of rimantadine in healthy subjects.
    Holazo AA; Choma N; Brown SY; Lee LF; Wills RJ
    Antimicrob Agents Chemother; 1989 Jun; 33(6):820-3. PubMed ID: 2764530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M; Pervaiz F
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of a single dose of rimantadine in young adults and children.
    Anderson EL; Van Voris LP; Bartram J; Hoffman HE; Belshe RB
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1140-2. PubMed ID: 3662473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects.
    Strenkoski-Nix LC; Ermer J; DeCleene S; Cevallos W; Mayer PR
    Am J Health Syst Pharm; 2000 Aug; 57(16):1499-505. PubMed ID: 10965395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of pseudoephedrine and triprolidine from combination and single-ingredient products.
    Williams BO; Liao SH; Lai AA; Arnold JD; Perkins JG; Blum MR; Findlay JW
    Clin Pharm; 1984; 3(6):638-43. PubMed ID: 6509877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eslicarbazepine acetate (BIA 2-093) : relative bioavailability and bioequivalence of 50 mg/mL oral suspension and 200mg and 800mg tablet formulations.
    Fontes-Ribeiro C; Nunes T; Falcão A; Neta C; Lima R; Tavares S; Almeida L; Macedo T; Soares-da-Silva P
    Drugs R D; 2005; 6(5):253-60. PubMed ID: 16128595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability and bioequivalence of a darunavir 800-mg tablet formulation compared with the 400-mg tablet formulation.
    Kakuda TN; Leopold L; Timmers M; Van De Casteele T; Hillewaert V; Tomaka FL; Hoetelmans RM
    Int J Clin Pharmacol Ther; 2014 Sep; 52(9):805-16. PubMed ID: 25109510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.